Stay updated on Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Sign up to get notified when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T00:35:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A glossary feature was added to the page, and there are minor text/capitalization changes plus a new version label (Revision: v3.4.0). The core study content and user actions remain unchanged.
    Difference
    0.2%
    Check dated 2026-01-28T21:44:57.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision: v3.3.4 was added and Revision: v3.3.3 was removed.
    Difference
    0.1%
    Check dated 2026-01-14T04:09:06.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Locations section reorganized under a single Locations heading listing Florida and North Carolina; the HHS Vulnerability Disclosure link was removed and the page revision updated from v3.3.2 to v3.3.3.
    Difference
    0.3%
    Check dated 2025-12-23T21:12:40.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no study content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:55:49.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The government funding status notice has been removed; core trial information remains unchanged, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:13.000Z thumbnail image

Stay in the know with updates to Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Radiation+Chemo+Ipilimumab+Nivolumab in Stage III NSCLC Clinical Trial page.